Sofinnova Venture Partners X, L.P. Insider Profile
4 Followers
Sofinnova Venture Partners X, L.P., Ten Percent Owner at Vera Therapeutics, holds 3.47M shares in Vera Therapeutics (Ticker: VERA), holds 6.07M shares in Cincor Pharma (Ticker: CINC), holds 3.76M shares in Jade Biosciences (Ticker: JBIO). Most recently, Sofinnova Venture Partners X, L.P. Bought ― shares of Vera Therapeutics on Feb 08, 2023 for an estimated value of $2.00M.
Sofinnova Venture Partners X, L.P.'s Trading History
| VERAVera Therapeutics | Feb 08, 2023 | Ten Percent Owner | Informative Buy | 2.00M | $97.43M | |
| CINCCincor Pharma | Aug 15, 2022 | ― | Informative Buy | 15.00M | $176.51M | |
| JBIOJade Biosciences | Jul 06, 2021 | Ten Percent Owner | Uninformative Buy | ― | $60.67M | |
| BOLTBolt Biotherapeutics | Feb 09, 2021 | Ten Percent Owner | Uninformative Buy | ― | $16.75M | |
| INZYInozyme Pharma | Jul 28, 2020 | ― | Uninformative Buy | ― | $8.11M | |
| AKUSAKOUOS | Jul 01, 2020 | ― | Uninformative Buy | ― | $20.14M |
You May Also Like
Sofinnova Venture Partners X, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Sofinnova Venture Partners X, L.P.?
The percentage of profitable transactions made by Sofinnova Venture Partners X, L.P. is 38%.
What is the average return per transaction made by Sofinnova Venture Partners X, L.P.?
The average return per transaction made by Sofinnova Venture Partners X, L.P. is 39.80%.
What stocks does Sofinnova Venture Partners X, L.P. hold?
Sofinnova Venture Partners X, L.P. holds: VERA, AKUS, INZY, BOLT, JBIO, CINC stocks.
What was Sofinnova Venture Partners X, L.P.’s latest transaction?
Sofinnova Venture Partners X, L.P.’s latest transaction was an Informative Buy of $2.00M.
What was Sofinnova Venture Partners X, L.P.'s most profitable transaction?
Sofinnova Venture Partners X, L.P.’s most profitable transaction was an Informative Buy of VERA stock on February 8, 2023. The return on the trade was 418.70%.
What is Sofinnova Venture Partners X, L.P.'s role in Vera Therapeutics?
Sofinnova Venture Partners X, L.P.'s role in Vera Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
